Human Reproduction, Vol. 11, No. 11, pp. 2400-2404, 1996
© 1996 European Society of Human Reproduction and Embryology
research-article |
Endocrinology: Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization
Department of Obstetrics and Gynecology, Faculty of Medicine-University of Barcelona, Hospital Clinic i Provincial Barcelona, Spain
Correspondence: 1To whom correspondence should be addressed at: Department of Obstetrics and Gynaecology, Hospital Clinic i Provincial, C/Casanova 143, 08036-Barcelona, Spain
The use of pure follicle stimulating hormone (pFSH) and highly purified FSH (FSH-HP) versus the combinations pFSH/human menopausal gonadotrophin (HMG) and FSH-HP/HMG, respectively, was compared for stimulating follicular development after gonadotrophin-releasing hormone agonist (GnRHa) suppression in women undergoing in-vitro fertilization (TVF)—embryo transfer. Two consecutive prospective, randomized studies were carried out at the Assisted Reproduction Unit of the Hospital Clínic i Provincial in Barcelona, a tertiary care setting. Two groups of 188 (study 1) and 252 (study 2) consecutive infertile patients respectively, scheduled for IVF-embryo transfer were included. Pretreatment with leuprolide acetate (long protocol) was followed by gonadotrophin treatment in all patients. In study 1, 92 patients received i.m. pFSH alone (group pFSH) and 96 were treated with the combination of i.m. pFSH and i.m. HMG (group HMG-1). In study 2, 123 patients received s.c. FSH-HP alone (group FSH-HP) and 129 patients were given the combination of s.c FSH-HP and i.m. HMG (group HMG-2). Main outcome measures included follicular development, oocyte retrieval, fertilized oocytes, duration and dose of gonadotrophin therapy, and clinical pregnancy. There were no significant differences between pFSH and pFSH/HMG nor between FSH-HP and FSH-HP/HMG cycles with regard to the number of ampoules of medication used, day of human chorionic gonadotrophin (HCG) administration, mean peak serum oestradiol concentrations, number of follicles punctured, and number of oocytes aspirated, embryos transferred, or pregnancies. We conclude that urinary FSH (either purified of highly purified) alone is as effective as the conventional combination of urinary FSH/HMG for ovarian stimulation under pituitary suppression in IVF cycles. Therefore, they can be used interchangeably in FVF programmes.
Key words: highly purified FSH/TVF/ovarian stimulation/pure FSH/urofollitrophins
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Dias, R. McNamee, and A. Vail Evidence of improving quality of reporting of randomized controlled trials in subfertility Hum. Reprod., October 1, 2006; 21(10): 2617 - 2627. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. de Llanos, J. L. Ballesca, C. Gazquez, E. Margarit, and R. Oliva High frequency of gr/gr chromosome Y deletions in consecutive oligospermic ICSI candidates Hum. Reprod., January 1, 2005; 20(1): 216 - 220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Tesarik and C. Mendoza Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence Hum. Reprod., December 1, 2002; 17(12): 3129 - 3137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Balasch The potential value of mid-follicular phase LH Hum. Reprod., February 1, 2002; 17(2): 518 - 520. [Full Text] [PDF]
|
|
|
|
|
|
S. Burgues The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain Hum. Reprod., December 1, 2001; 16(12): 2525 - 2532. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. Levy, J. M. Navarro, G. L. Schattman, O. K. Davis, and Z. Rosenwaks The role of LH in ovarian stimulation: Exogenous LH: let's design the future Hum. Reprod., November 1, 2000; 15(11): 2258 - 2265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Ballesca, J. Balasch, J. M Calafell, R. Alvarez, F. Fabregues, M J. M. de Osaba, C. Ascaso, and J. A. Vanrell Serum inhibin B determination is predictive of successful testicular sperm extraction in men with non-obstructive azoospermia Hum. Reprod., August 1, 2000; 15(8): 1734 - 1738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Filicori, G. E. Cognigni, S. Taraborrelli, D. Spettoli, W. Ciampaglia, C. Tabarelli de Fatis, and P. Pocognoli Luteinizing Hormone Activity Supplementation Enhances Follicle-Stimulating Hormone Efficacy and Improves Ovulation Induction Outcome J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2659 - 2663. [Abstract] [Full Text]
|
|